Early and intensive treatment of age-related macular degeneration with bevacizumab is associated with greater long-term improvements in visual acuity than are ranibizumab or aflibercept, a real ...

How you prepare your morning cup of joe could be linked to an eye disease that affects nearly 20 million Americans.

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

Choroidal neovascularization in myopic macular degeneration can cause vision loss, but advances in treatment options may prevent that outcome for many. Learn more about these sight-saving therapies.

In this video, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses his presentation at Clinical Trials at the Summit on the use of EyePoint’s Duravyu in neovascular age-related ...

A new study suggests that measuring specific immune system proteins in the blood could help predict which patients with intermediate age-related macular degeneration (AMD) are most likely to ...

Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...

Macular edema is an eye condition that occurs when fluids builds up in the macula. Learn about symptoms of the condition, causes, treatment options, and more.

The treatment of diabetic macular oedema (DMO) likely involves a series of treatment episodes separated by gaps during which ...